CSIMarket
 


Nascent Biotech Inc  (NBIO)
Other Ticker:  
 
 

NBIO's Revenue Growth by Quarter and Year

Nascent Biotech Inc's Revenue results by quarter and year




NBIO Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter March - 0.00 1.00 0.75
III Quarter December 0.00 0.00 0.00 0.00
II Quarter September 0.00 0.00 0.00 0.00
I Quarter June 0.00 0.00 0.00 0.00
FY   0.00 0.00 1.00 0.75



NBIO Revenue third quarter 2024 Y/Y Growth Comment
Nascent Biotech Inc in the third quarter 2024 recorded of $ 0.00 millions.

Looking into third quarter 2024 results within Major Pharmaceutical Preparations industry 32 other companies have achieved higher Revenue growth. While Nascent Biotech Inc' s Revenue no change of % ranks overall at the positon no. 807 in the third quarter 2024.




NBIO Revenue ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter March - - 33.33 % -
III Quarter December - - - -
II Quarter September - - - -
I Quarter June - - - -
FY   - - 33.33 % -

Financial Statements
Nascent Biotech Inc's third quarter 2024 Revenue $ 0.00 millions NBIO's Income Statement
Nascent Biotech Inc's third quarter 2023 Revenue $ 0.00 millions Quarterly NBIO's Income Statement
New: More NBIO's historic Revenue Growth >>


NBIO Revenue (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter March - - - -
III Quarter December - - - -
II Quarter September - - - -
I Quarter June - - - -
FY (Year on Year)   - - 33.33 % -




Revenue third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #33
Healthcare Sector #84
Overall #807

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #33
Healthcare Sector #84
Overall #807
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Nascent Biotech Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NBIO's III. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NBIO's III. Quarter Q/Q Revenue Comment


Nascent Biotech Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 1.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - 6.57 % -99.97 % -
Seq. Revenue Growth (TTM) Overall Ranking # 807 # 2449 # 3696 # 3604 # 0




Cumulative Revenue growth Comment
Nascent Biotech Inc realized trailing twelve months of $ 0 millions, in the Dec 31 2023, compare to Revenue of $ 1 millions a year ago.

Nascent Biotech Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 33
Sector # 84
S&P 500 # 807
Cumulative Revenue growth Comment
Nascent Biotech Inc realized trailing twelve months of $ 0 millions, in the Dec 31 2023, compare to Revenue of $ 1 millions a year ago.

Nascent Biotech Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 33
Sector # 84
S&P 500 # 807




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NBIO's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for NBIO's Competitors
Revenue Growth for Nascent Biotech Inc's Suppliers
Revenue Growth for NBIO's Customers

You may also want to know
NBIO's Annual Growth Rates NBIO's Profitability Ratios NBIO's Asset Turnover Ratio NBIO's Dividend Growth
NBIO's Roe NBIO's Valuation Ratios NBIO's Financial Strength Ratios NBIO's Dividend Payout Ratio
NBIO's Roa NBIO's Inventory Turnover Ratio NBIO's Growth Rates NBIO's Dividend Comparisons



Companies with similar Revenue no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2023
Healthcare Services Group Inc -0.04%$ -0.042 millions
Integra Lifesciences Holdings Corp-0.25%$ -0.247 millions
National Research Corporation-0.37%$ -0.375 millions
The Beauty Health Company-0.63%$ -0.633 millions
3m Company-0.82%$ -0.817 millions
Viatris Inc -1.00%$ -0.998 millions
Quest Diagnostics Inc-1.93%$ -1.929 millions
Koru Medical Systems Inc-2.16%$ -2.161 millions
Envista Holdings Corporation-2.30%$ -2.300 millions
Zynex inc -3.11%$ -3.114 millions
Baxter International Inc -3.55%$ -3.550 millions
Caribou Biosciences Inc -3.63%$ -3.629 millions
Gilead Sciences Inc -3.72%$ -3.722 millions
Lifevantage Corp-3.92%$ -3.921 millions
Avantor Inc -4.02%$ -4.022 millions
Escalon Medical Corp -4.53%$ -4.533 millions
Inovio Pharmaceuticals Inc -4.55%$ -4.553 millions
Optinose Inc -4.76%$ -4.756 millions
Cryoport inc -5.13%$ -5.133 millions
Hookipa Pharma inc -5.38%$ -5.378 millions
Abbvie inc -5.42%$ -5.423 millions
Hologic Inc-5.69%$ -5.688 millions
Encision Inc -6.08%$ -6.083 millions
Biogen Inc -6.20%$ -6.199 millions
Curis Inc -6.62%$ -6.616 millions
Bio rad Laboratories Inc -6.62%$ -6.621 millions
Charles River Laboratories International inc -7.85%$ -7.853 millions
Cara Therapeutics inc -7.88%$ -7.881 millions
Arcus Biosciences Inc -7.89%$ -7.889 millions
Qiagen N v -8.67%$ -8.666 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com